For Q3, we are slightly above consensus on EBIT but below on net profit. We expect Lyko’s results to be weighed down by continuously high financial costs. In our view, focus will remain on its European market, the efforts to improve its group gross margin, and the cash flow position (net debt/EBITDA of c4.4x at end-Q2). We reiterate our SELL and SEK95 target price, reflecting its stretched balance sheet and our belief that it will take time to properly balance growth and profitability.
Although it is too early to draw any firm conclusions, Q2 showed some positive signs, with improved EBIT margins YOY across the company’s regions and a stronger cash position. However, the gross margin continued to narrow, and current debt is pressured at a net debt/EBITDA of 4.36x. We reiterate our SELL and SEK95 target price.
Soft Q2 report. Despite EBIT margin growth in both regions and stronger FCF, the gross margin was below consensus, the high financial expenses offset net profit (which was negative) and the company’s net debt/EBITDA (including IFRS16) grew to 4.63x. We expect consensus 2024–2025e EBIT and net profit to come down by 2–4% and c40–16%, respectively. We believe a negative share price reaction is warranted today.
Being below consensus on EBIT and net profit, we are cautious ahead of Lyko’s Q2 report. We expect focus to be on comments on Europe, efforts to improve the gross margin, and its cash flow position (bearing in mind the net debt/EBITDA of c4.6x at end-Q1). We reiterate our SELL and SEK95 of target price, reflecting Lykos’ stretched balance sheet and uncertainty on how the company navigates growth and profitability.
Following the Q1 report, we believe Lyko will not only have to make more substantial progress in balancing growth and cost control, but also consider new funding options more seriously. With financial expenses eating up earnings, its current debt position, and stretched balance sheet (net debt/EBITDA c4.6x), we have downgraded to SELL (HOLD) and cut our target price to SEK95 (128).
The Q1 report was weak, with the gross margin down c120bp YOY, a net loss, and a higher-than-expected net debt/EBITDA (incl. IFRS 16) of c4.6x. We expect consensus 2024–2025e EBIT to come down by c2–4% and net profit by c20–30%. We believe a negative share price reaction is warranted today.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.